NEW X-RAY CONTRAST AGENTSPROF. DR. ERNST FELDERPROF. DR. DAVIDE PITRE
Towards targeted MRI: new MRI contrast agents for sialic acid detection. Frullano,L. et al. Chemistry . 2004Frullano, L.; Rohovec, J.; Aime, S.; Maschmeyer, T.; Prata, M. I.; Predroso de Lima, J. J.; Geraldes, C. F. C. G.; Peters, J. A. Towards targeted MRI: new ...
March 9, 2023 — Contrast agents used in MRI scans to improve the clarity of imaging for diagnostic accuracy, accumulate in the brain and body of every patient, and carry an FDA “black box” warning about gadolinium, a heavy metal they use to generate contrast. Now, a revolutionary ...
New Classes of MRI Contrast Agents. In: Krause W, editor. Contrast Agents I. Vol 221. Berlin/Heidelberg: Springer Verlag; 2002: 123.Jacques,V.,Desreux,J. F.New classes of MRI contrast agents. Contrast Agents I . 2002Jacques V, Desreux JF. New classes of MRI contrast agents. Top ...
(MRI) exams. Contrast enhanced MRI is a widely used diagnostic tool with over 30 million procedures performed annually. Currently, gadolinium-based contrast agents (GBCAs) are used for this purpose, but recently concerns have been raised about the long-term safety of the gadolinium metal ion. ...
Purpose To compare three new macromolecular polyethylene glycol (PEG) -core dendrimeric gadolinium(Gd)-based MRI contrast agents for their applicability in quantitative assays of endothelial leakiness and tissue vascular density for the differentiation of cancer from normal soft tissues. Materials and Met...
The team has already used the new combination of agents to assemble MRI, CT and optical imaging data of different 3-D tissues, allowing for visualization from the cellular- to whole-tissue level with complementary contrast mechanisms. They hope to use it to develop an "atlas for cancer systems...
The team has already used the new combination of agents to assemble MRI, CT and optical imaging data of different 3-D tissues, allowing for visualization from the cellular- to whole-tissue level with complementary contrast mechanisms. They hope to use it to develop an "atlas for cancer systems...
PURPOSE With the introduction of a newly approved high relaxivity MR contrast agent across a health care system encompassing several hospitals and imaging centers, there was concern as to the actual adverse reaction rate that would be experienced with this new agent. Data were collected prospectively...
Barge, A.; Cravotto, G.; Robaldo, B.; Gianolio, E.; Aime, S. New CD deriva- tives as self-assembling contrast agents for magnetic resonance imaging (MRI). J. Inclusion Phenom. Macrocycl. Chem., 2007, 57, 489-495.Barge, A., Cravotto, G., Robaldo, B., Gianolio, E., ...